| Pharmaceutical Information |
| Drug Name |
Laronidase |
| Drug ID |
BADD_D01249 |
| Description |
Human recombinant alpha-L-iduronidase, 628 residues (mature form), produced by recombinant DNAtechnology in a Chinese hamster ovary cell line. Laronidase is a glycoprotein with a molecular weight of approximately 83 kD. The predicted amino acid sequence of the recombinant form, as well as the nucleotide sequence that encodes it, are identical to a polymorphic form of human a-L-iduronidase. It contains 6 N-linked oligosaccharide modification sites. |
| Indications and Usage |
For the treatment of mucopolysaccharidosis |
| Marketing Status |
Prescription |
| ATC Code |
A16AB05 |
| DrugBank ID |
DB00090
|
| KEGG ID |
D04670
|
| MeSH ID |
Not Available
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D03LUN
|
| NDC Product Code |
58468-0070; 68135-000 |
| Synonyms |
Not Available |
|
| Chemical Information |
| Molecular Formula |
Not Available |
| CAS Registry Number |
210589-09-6 |
| SMILES |
Not Available |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
